Dementia309.

916 views

Published on

Dementia& Alzheimer’s disease.

Published in: Health & Medicine
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
916
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
41
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Dementia309.

  1. 1. Dementia Prepared by: Dr. Mohamed Sheikhani. From BMJ Feb 2009.
  2. 2. <ul><li>Dementia is a clinical syndrome characterised by a cluster of symptoms/signs manifested by difficulties in memory, disturbances in language, psychological&psychiatric changes, &impairments in ADL. </li></ul><ul><li>Alzheimer’s disease is a specific disease entity&is the commonest cause of dementia. </li></ul>
  3. 3. Introduction:
  4. 4. The burden: <ul><li>12 million worldwide have dementia, increase to 25 million by 2040. </li></ul><ul><li>The annual cost of care is £17bn (>heart disease, stroke,cancer). </li></ul><ul><li>Dementia is one of the main causes of disability in later life, contributes 11.2% of all years lived with disability—higher than stroke (9.5%), musculoskeletal disorders (8.9%), heart disease (5%), & cancer (2.4%). </li></ul>
  5. 5. Benefits of early diagnosis: <ul><li>Identification of treatable physical & psychiatric causes </li></ul><ul><li>Treatment of co-morbid conditions. </li></ul><ul><li>Initiation of psychosocial support </li></ul><ul><li>Start of pharmacological symptomatic treatments. </li></ul>
  6. 6. Barriers of early diagnosis: <ul><li>Early recognition is not easy because of: </li></ul><ul><li>The insidious/variable onset of the syndrome, sometimes without a clear demarcation until late in the disease process. </li></ul><ul><li>Patients, families& general practitioners may all be reluctant to diagnose dementia because it is such a serious& largely unmodifiable disease that still carries a huge burden of stigma. </li></ul><ul><li>Family members may gradually take over social roles from the patient, protecting him or her from difficulties in daily life&delaying the conscious recognition of the disorder by offsetting impairments. </li></ul>
  7. 7. Suspicion &diagnosis: <ul><li>Depends on the triad of patient report, informant history& assessment of cognitive function. </li></ul><ul><li>Awareness that memory problems in old age, particularly when deteriorating& interfering with daily activities, may be the harbinger of dementia is the most important factor in recognition. </li></ul><ul><li>The most commonly used cognitive assessment tool is the minimental state examination, scored out of 30: a score of <24 suggests dementia&performance requires intact language &dependent on educational attainment& cultural background. </li></ul><ul><li>It can take up to 20 minutes to complete& so may be practical for use only in secondary care. </li></ul><ul><li>The GP assessment of cognition test& 2 other cognitive screening tests (the mini-cog assessment instrument& the memory impairment screen) are as clinically /psychometrically robust as &more appropriate for use in primary care. </li></ul><ul><li>The six item cognitive impairment test designed for use in general practice& produces more reliable results than the MMSE. </li></ul>
  8. 9. Dementia diagnosis: <ul><li>1.GP recommended to perform some routine investigations (standard blood screening, CXR if H/O chest problems& ECG if heart disease is suspected) before referring the patient for a specialist secondary care </li></ul><ul><li>2. The exclusion of potentially reversible conditions ( as normal pressure hydrocephalus) & the confirmation of the dementia pathology via detailed neurocognitive assessment &if available, CT. </li></ul><ul><li>This allows the subtyping of dementia important for prognosis & treatment, as Alzheimer’s disease, the only one of the dementias in which symptom modification with drug treatment is possible. </li></ul><ul><li>The diagnostic process may be interative&extended. </li></ul><ul><li>From first symptom to presentation to GP takes about 18 months, with a similar time to diagnosis thereafter. </li></ul><ul><li>This time period can be shortened by using a structured educational intervention based on adult learning principles &conducted as a workshop in general practice. </li></ul>
  9. 11. Dementia or depresion: <ul><li>The comorbidity of depressive dementia symptoms is high. </li></ul><ul><li>People with dementia syndrome have high rates of depression & people with depression often have prominent complaints of memory loss, neuropsychological deficits & often organic brain changes. </li></ul><ul><li>The awareness of the overlap between these disorders is clinically important because clinical trials have shown that antidepressant treatment can be beneficia. </li></ul>
  10. 12. Subtype of dementia : <ul><li>The causes are important because different types of dementia can have different courses, with different patterns of symptoms&can respond differently to treatment: </li></ul><ul><li>Alzheimer’s disease can be modified with cholinesterase inhibitors </li></ul><ul><li>Lewy body dementia differs from the other types because of the dominance of motor symptoms (like Parkinson’s disease)& the salience of visual hallucinations&antipsychotic drugs may have adverse effects. </li></ul><ul><li>In vascular disease means co-morbidities can be treated. </li></ul><ul><li>It is important to differentiate between different types of dementia because patients/relatives have the right to a definitive diagnosis. </li></ul>
  11. 18. Mental capacity assessment: <ul><li>The Mental Capacity Act 200512 is complex& all those working with older people need to be aware of its principle: </li></ul><ul><li>Adults are assumed to have capacity unless proved otherwise </li></ul><ul><li>Individuals must be given all available support before concluding that they cannot make decisions for themselves </li></ul><ul><li>People must retain the right to make what may be seen as eccentric & unwise decisions. </li></ul><ul><li>Anything done for a person without capacity must be in their best interests &should restrict their rights& basic freedoms as little as possible. </li></ul><ul><li>Doctors are being asked to assess capacity in people with cognitive impairment. </li></ul><ul><li>The medical assessment is based on a person’s ability to understand what is being asked, retain the information long enough to make a judgment& be able to express that judgment& may vary over time &are specific to a decision. </li></ul>
  12. 19. Psychiatric/behavioral symptoms treatment: <ul><li>As agitation, pacing around, wandering, getting lost. </li></ul><ul><li>up to 90% will experience such symptoms to some degree at some time, particularly in the middle&later stages , can lead to high levels of stress in carers& may be one of the crucial factors leading to care home admission. </li></ul><ul><li>Management requires a thorough clinical assessment to exclude treatable causes such as infection or pain. </li></ul><ul><li>Non-drug approaches should be used where possible& specialist advice sought. </li></ul><ul><li>20-50% of people with dementia in institutional care receive antipsychotic drugs,despite widespread concerns over their hazards. </li></ul>
  13. 21. Alzheimer’s disease <ul><li>A chronic progressive neurodegenerative disorder characterised by 3 primary groups of symptoms </li></ul><ul><li>1. Cognitive dysfunction( memory loss, language difficulties); executive dysfunction ( loss of higher level planning & intellectual coordination skills). </li></ul><ul><li>2.Psychiatric symptoms/behavioural disturbances— depression, hallucinations, delusions, agitation—termed non-cognitive symptoms </li></ul><ul><li>3. Difficulties with performing ADL ( “instrumental” for more complex activities such as driving/ shopping & “basic” for dressing / eating unaided). </li></ul><ul><li>The symptoms of Alzheimer’s disease progress from mild symptoms of memory loss to very severe dementia. </li></ul><ul><li>Increasingly, coexistence of vascular disease& Alzheimer’s disease is being recognised clinically, pathologically& epidemiologically. </li></ul>

×